Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Precision Therapeutics Inc. AIPT

Precision Therapeutics Inc. (NASDAQ: AIPT) Secures Lab Status in NIIMBL Drug Safety Grant, Furthers Aim of Improving Medical Care

The global precision medicine market is expected to reach revenues of over $216.75 billion by 2028, propelled by a growing interest in personalized approaches to disease treatments and the application of new technologies Precision Therapeutics and its three wholly owned … Continue reading

Posted in Precision Therapeutics Inc. AIPT | Leave a comment